tiprankstipranks
Trending News
More News >
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market
Advertisement

Radiopharm Theranostics Limited (RAD) Drug Pipeline

Compare
21 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
177Lu-Betabart
Cervical Cancer, Ovarian Cancer, Colorectal Cancer, Castration-Resistant Prostate Cancer (Crpc), Endometrial Cancer, Esophageal Squamous Cell Carcinoma (Escc), Nsclc (Non-Small Cell Lung Cancer), Tnbc, Triple Negative Breast Cancer, Small Cell Lung Cancer (Sclc ), Head &Amp; Neck Squamous Cell Carcinoma (Hnscc)
Phase I/II
Not Yet Recruiting
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Sep 11, 2025
177Lu-Rad202
Advanced Solid Tumors, Her2 Gene Mutation
Early Phase I
Recruiting
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
Feb 07, 2025
Rad101 (18F-Fpia)
Brain Metastases From Solid Tumors
Phase II
Recruiting
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Dec 19, 2024
177Lu-Rad204
Non Small Cell Lung Cancer, Cutaneous Melanoma, Endometrial Cancer, Hnscc, Pdl1 Gene Mutation, Small Cell Lung Cancer ( Sclc ), Tnbc, Triple Negative Breast Cancer
Early Phase I
Recruiting
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Feb 22, 2024
Rad301 ([68Ga]-Rad301)
Healthy Volunteers, Pancreatic Ductal Adenocarcinoma
Phase I
Recruiting
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer
Mar 12, 2023

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Radiopharm Theranostics Limited (RAD) have in its pipeline
      RAD is currently developing the following drugs: 177Lu-Betabart, 177Lu-Rad202, Rad101 (18F-Fpia). These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis